Trial ID or NCT#



recruiting iconRECRUITING


This extended clinical investigation is a multicenter, prospective, sing arm study intended to provide continued access of the Exablate(R) Model 2100 device (Exablate Prostate) to patients for treatment of prostate lesions and collect additional safety and effectiveness data during the 510(k) preparation and review period.

Official Title

A Continued Access Study to Evaluate Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Eligibility Criteria

Ages Eligible for Study: Older than 50 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No


Geoffrey Sonn
Geoffrey Sonn
Urologic oncologist, Urologist, Urologic specialist, Genitourinary specialist
Assistant Professor of Urology and, by courtesy, of Radiology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.


Ned U. Realiza
(650) 498-8496